Status:

COMPLETED

SMART-IBD App Trial

Lead Sponsor:

Children's Hospital Medical Center, Cincinnati

Conditions:

Inflammatory Bowel Diseases

IBD

Eligibility:

All Genders

13-17 years

Phase:

NA

Brief Summary

The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will co...

Eligibility Criteria

Inclusion

  • Patient diagnosed with Crohn's disease, ulcerative colitis, or indeterminate colitis (collectively IBD)
  • Prescribed at least one medication used to treat IBD, regardless of route of administration
  • Access to internet or wi-fi or data plan and access to smartphone
  • English fluency for patient and clinician

Exclusion

  • Diagnosis of pervasive developmental disorder in patient or caregiver as determined by medical chart review
  • Diagnosis of serious mental illness (e.g., schizophrenia) in patient or caregiver as determined by medical chart review

Key Trial Info

Start Date :

December 14 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 28 2023

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT06023667

Start Date

December 14 2022

End Date

December 28 2023

Last Update

August 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229